跳至主要内容
临床试验/CTRI/2024/09/074243
CTRI/2024/09/074243招募中不适用

To understand the antimicrobial prescription patterns in patients with terminal or life-limiting illness in intensive care unit- An observational study

Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2024年10月3日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
130
试验地点
1
主要终点
To understand the antimicrobial prescription patterns in patients with terminal or life-limiting illness in intensive care unit

研究概览

简要总结

The general goal of antimicrobial therapy is to increase patient’s survival and cure infectious diseases. Because antimicrobial agents are unable to alter the progression of underlying diseases or rather sometimes can prolong suffering in patients at the end-of-life, the goal of prolonging life should be weighed against the risk of prolonging suffering.  Thus, the goal of antimicrobial therapy shifts from improving survival to symptom control with a shift in the goal of care from cure to palliation.  The goal of antimicrobial therapy for terminal patients at an early stage can include symptom control and improvement in survival while maintaining the quality of life.  Antimicrobials however do not change the natural course of disease.  Also, no difference in frequencies of documented symptoms with the use of antimicrobials was seen in a retrospective study at end-of-life.

We do not have information from the Indian subcontinent.  Results of this audit should serve as a living document for re-visiting antimicrobial prescription practices by physician prescribers and set up antimicrobial stewardship guidelines for terminally ill patients such that these can be viewed as aggressive care in end-of-life situations.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Adult ICU
  • Age more than 18 years
  • All genders
  • Patients with terminal or life-limiting illness.

排除标准

  • Age less than 18 years.

结局指标

主要结局

To understand the antimicrobial prescription patterns in patients with terminal or life-limiting illness in intensive care unit

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Sonali Vadi

Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute

研究点 (1)

Loading locations...

相似试验